Product Brochure: Early-Stage CMC Testing For Dry Powder Inhaler (DPI) Products

Early-stage pharmaceutical and biopharmaceutical companies developing products for nasal and pulmonary dosage forms can mitigate the risks of product development by relying on a trusted resource that contributes expertise in materials, reliable analytical data and quality project management. West Analytical Services provides early-stage pharmaceutical and biopharmaceutical clients with consultation and full project management for testing delivery devices for pulmonary and nasal dosage forms.

West offers cGMP-compliant analytical testing studies of horizontal and vertical Dry Powder Inhaler products for Chemistry, Manufacturing and Controls documentation (CMC). West’s professionals understand the market entry challenges for early-stage pharmaceutical and biopharmaceutical companies that are developing dry powder dosage forms. West’s program management service is designed to provide expert information to help clients navigate this tightly regulated environment. Our service provides clients with the assurance needed to make informed decisions for each phase of development through commercialization. Submitted by West Analytical Services